BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36522349)

  • 1. Burkitt lymphoma.
    López C; Burkhardt B; Chan JKC; Leoncini L; Mbulaiteye SM; Ogwang MD; Orem J; Rochford R; Roschewski M; Siebert R
    Nat Rev Dis Primers; 2022 Dec; 8(1):78. PubMed ID: 36522349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
    Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma.
    Xu L; Zhang M; Tu D; Lu Z; Lu T; Ma D; Zhou Y; Zhang S; Ma Y; Yan D; Wang X; Sang W
    J Pharmacol Exp Ther; 2023 Dec; 387(3):288-298. PubMed ID: 37875309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
    Molina E; García-Gutiérrez L; Junco V; Perez-Olivares M; de Yébenes VG; Blanco R; Quevedo L; Acosta JC; Marín AV; Ulgiati D; Merino R; Delgado MD; Varela I; Regueiro JR; Moreno de Alborán I; Ramiro AR; León J
    Oncogene; 2023 Nov; 42(45):3358-3370. PubMed ID: 37773203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
    Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
    Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt lymphoma- a rare but challenging lymphoma.
    Casulo C; Friedberg JW
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):279-284. PubMed ID: 30213397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.
    Bellan C; Lazzi S; Hummel M; Palummo N; de Santi M; Amato T; Nyagol J; Sabattini E; Lazure T; Pileri SA; Raphael M; Stein H; Tosi P; Leoncini L
    Blood; 2005 Aug; 106(3):1031-6. PubMed ID: 15840698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
    Bornkamm GW
    Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.
    Grande BM; Gerhard DS; Jiang A; Griner NB; Abramson JS; Alexander TB; Allen H; Ayers LW; Bethony JM; Bhatia K; Bowen J; Casper C; Choi JK; Culibrk L; Davidsen TM; Dyer MA; Gastier-Foster JM; Gesuwan P; Greiner TC; Gross TG; Hanf B; Harris NL; He Y; Irvin JD; Jaffe ES; Jones SJM; Kerchan P; Knoetze N; Leal FE; Lichtenberg TM; Ma Y; Martin JP; Martin MR; Mbulaiteye SM; Mullighan CG; Mungall AJ; Namirembe C; Novik K; Noy A; Ogwang MD; Omoding A; Orem J; Reynolds SJ; Rushton CK; Sandlund JT; Schmitz R; Taylor C; Wilson WH; Wright GW; Zhao EY; Marra MA; Morin RD; Staudt LM
    Blood; 2019 Mar; 133(12):1313-1324. PubMed ID: 30617194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
    Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe.
    Vaillant V; Reiter A; Zimmermann M; Wagner HJ
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27752. PubMed ID: 30977593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
    Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells.
    Sall FB; Shmakova A; Karpukhina A; Tsfasman T; Lomov N; Canoy RJ; Boutboul D; Oksenhendler E; Toure AO; Lipinski M; Wiels J; Germini D; Vassetzky Y
    J Med Virol; 2023 Mar; 95(3):e28633. PubMed ID: 36866703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stage of Epstein-Barr virus lytic infection leading to the "starry sky" pattern formation in endemic Burkitt lymphoma.
    Fujita S; Buziba N; Kumatori A; Senba M; Yamaguchi A; Toriyama K
    Arch Pathol Lab Med; 2004 May; 128(5):549-52. PubMed ID: 15086279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology: clues to the pathogenesis of Burkitt lymphoma.
    Magrath I
    Br J Haematol; 2012 Mar; 156(6):744-56. PubMed ID: 22260300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro.
    Chen S; Wang Z; Dai X; Pan J; Ge J; Han X; Wu Z; Zhou X; Zhao T
    Cancer Sci; 2013 Jul; 104(7):826-34. PubMed ID: 23521217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.
    Moormann AM; Bailey JA
    Curr Opin Virol; 2016 Oct; 20():78-84. PubMed ID: 27689909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.